Back to Search Start Over

The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment

Authors :
Monica De Luise
Ivana Kurelac
Maria Iorio
Nikkitha Umesh Ganesh
Anna Maria Porcelli
Giuseppe Gasparre
Iorio M.
Ganesh N.U.
De Luise M.
Porcelli A.M.
Gasparre G.
Kurelac I.
Source :
Cancers, Cancers, Vol 13, Iss 5447, p 5447 (2021)
Publication Year :
2021
Publisher :
MDPI AG, 2021.

Abstract

Simple Summary Along with cancer cells, tumor mass also contains numerous types of non-malignant cell populations, all together contributing to an organ-like multicellular organization. This review underlines the importance of taking into consideration the effects metabolic drugs used for cancer therapy may exert on the cells of the tumor microenvironment. Abstract Metabolic reprogramming is a well-known hallmark of cancer, whereby the development of drugs that target cancer cell metabolism is gaining momentum. However, when establishing preclinical studies and clinical trials, it is often neglected that a tumor mass is a complex system in which cancer cells coexist and interact with several types of microenvironment populations, including endothelial cells, fibroblasts and immune cells. We are just starting to understand how such populations are affected by the metabolic changes occurring in a transformed cell and little is known about the impact of metabolism-targeting drugs on the non-malignant tumor components. Here we provide a general overview of the links between cancer cell metabolism and tumor microenvironment (TME), particularly focusing on the emerging literature reporting TME-specific effects of metabolic therapies.

Details

ISSN :
20726694
Volume :
13
Database :
OpenAIRE
Journal :
Cancers
Accession number :
edsair.doi.dedup.....375e42d5d0354fca4afe7ab351e5d73f